FDA OKs sepsis panel from BioFire Diagnostics

06/26/2013 | GenomeWeb Daily News (free registration)

BioFire Diagnostics has secured FDA clearance for its FilmArray Blood Culture Identification, or BCID, panel, which the company says can detect more than 100 pathogens linked to sepsis. The device takes just about an hour to spot a pathogen in nine of 10 positive blood cultures and is meant to give hospitals a faster way to detect bloodstream infections.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA